
Bappu Rahman
About Bappu Rahman
Data last updated:
Bappu Rahman is a Director at Cavalry Laboratories Private Limited (since 2017) and Director at Cavalry Pharmaceuticals Private Limited (since 2014). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹84.8 Lakh; the largest is Cavalry Laboratories Private Limited at ₹81.7 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Nov 2017 | 2017 | ₹81.7 Lakh (FY 2024) | Active | |
| Director | 07 Aug 2014 | 2014 | ₹3.1 Lakh (FY 2025) | Active |
Board colleagues of Bappu Rahman
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahjabin Sultana | 07989939 | Cavalry Laboratories Private Limited | Director |
| Luich Rahman | 06884631 | Cavalry Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bappu Rahman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bappu Rahman
Bappu Rahman currently holds 2 directorships: Cavalry Laboratories Private Limited (Director, since 13 Nov 2017, revenue ₹81.7 Lakh (FY 2024)); Cavalry Pharmaceuticals Private Limited (Director, since 07 Aug 2014, revenue ₹3.1 Lakh (FY 2025)).
Bappu Rahman was first appointed on 07 Aug 2014 as Director at Cavalry Pharmaceuticals Private Limited. The most recent appointment on record is 13 Nov 2017 at Cavalry Laboratories Private Limited.
The 2 current companies of Bappu Rahman that report revenue have a combined latest revenue of ₹84.8 Lakh: Cavalry Laboratories Private Limited ₹81.7 Lakh (FY 2024); Cavalry Pharmaceuticals Private Limited ₹3.1 Lakh (FY 2025).
The current boards of Bappu Rahman's companies include Mahjabin Sultana (Cavalry Laboratories Private Limited), Luich Rahman (Cavalry Pharmaceuticals Private Limited).